机构：[1]Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[2]Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[3]Organ Transplantation Center, Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China四川省人民医院[4]HBPS Diseases Center for Diagnosis and Treatment of Leshan City, People’s Hospital of Leshan, Leshan, Sichuan 614000, China.
This study was supported by grants from the National
Natural Science Foundation of China (Nos. 81900576,
82100650) and the Science and Technological Supports
Project of Sichuan Province (Nos. 2019YJ0149,
22ZDYF1593), as well as the Post-Doctor Research
Project, West China Hospital, Sichuan University (No.
2020HXBH069).
第一作者机构：[1]Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China[*1]Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China
推荐引用方式(GB/T 7714)：
Qi Weili,Shen Junyi,Zhang Yu,et al.Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma[J].CHINESE MEDICAL JOURNAL.2023,136(19):2362-2364.doi:10.1097/CM9.0000000000002433.
APA：
Qi Weili,Shen Junyi,Zhang Yu,Gao Fengwei&Li Chuan.(2023).Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma.CHINESE MEDICAL JOURNAL,136,(19)
MLA：
Qi Weili,et al."Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma".CHINESE MEDICAL JOURNAL 136..19(2023):2362-2364
